Please find the session links next to their corresponding agenda item.
Thursday, March 17
11:00 AM
FDLI Welcome and Announcements
Khara L. Minter, Assistant Director, Training Programs, FDLI
Enter this session: https://fdli.zoom.us/j/83326367730
11:05 AM– 12:20 PM
Biosimilar Biological Products
Michelle Divelbiss, Associate, Covington & Burling LLP
Enter this session: https://fdli.zoom.us/j/83326367730
12:20 – 12:30 PM
Break
12:30 – 1:15 PM
Post-Approval Pharmacovigilance
Abeba Habtemariam, Counsel, Arnold & Porter LLP
Enter this session: https://fdli.zoom.us/j/83574882702
1:15 – 1:25 PM
Break
1:25 – 2:25 PM
Regulation of Biological Manufacturing
Neil Di Spirito, Partner, Brown Rudnick LLP
Enter this session: https://fdli.zoom.us/j/85611793888
2:25 – 2:35 PM
Break
2:35 – 3:35 PM
Regulation of Biological Product Marketing
Sarah Blankstein, Associate, Ropes & Gray LLP
Enter this session: https://fdli.zoom.us/j/88599592476
3:35 – 3:45 PM
Break
3:45 – 5:00 PM
Violations, Enforcement, and International Issues
Brian J. Malkin, Partner,McDermott Will & Emery
Enter this session: https://fdli.zoom.us/j/89489487983
5:00 PM
Adjournment